U.S. Specialty Stores Stock News

Conference appearance and media spotlight put Flex in focus Flex (FLEX) moved into the spotlight after Jim Cramer highlighted the stock on Mad Money and the company was scheduled to present at the KeyBanc Capital Markets 2026 Industrials & Basic Materials Conference in Boston. See our latest analysis for Flex. Those headlines have landed on a stock that already has strong momentum, with a 30 day share price return of 64.43% and a year to date share price return of 136.78%. The 1 year total...

We wouldn't blame Airbnb, Inc. ( NASDAQ:ABNB ) shareholders if they were a little worried about the fact that Brian...

McCormick (MKC) has drawn fresh attention after appointing Cindy Hoots, former Chief Digital Officer and CIO at AstraZeneca, to its Board of Directors. The move highlights a deeper focus on digital transformation and technology governance. See our latest analysis for McCormick. Despite the board refresh, recent trading has been weak. The 30 day share price return is down 5.71% and the year to date share price return is down 29.59%, while the 1 year total shareholder return is down 33.62%. If...

Why the frontMIND trial update matters for Incyte (INCY) Incyte (INCY) is in focus after reporting that its pivotal Phase 3 frontMIND trial in previously untreated high-risk diffuse large B-cell lymphoma showed a significant clinical benefit from adding tafasitamab and lenalidomide to standard R-CHOP therapy. The company highlighted a 25% reduction in the risk of disease progression or death with the combination regimen versus R-CHOP alone, supporting planned global regulatory submissions and...

Some Cimpress plc ( NASDAQ:CMPR ) shareholders may be a little concerned to see that the Executive VP & CFO, Sean...

Those following along with Sysco Corporation ( NYSE:SYY ) will no doubt be intrigued by the recent purchase of shares...

In May 2026, ServiceNow held its annual shareholder meeting where investors rejected a proposal to allow action by written consent, while the company deepened its AI role through new partnerships with Experian and Wipro and highlighted strong adoption of its platform on Amazon Web Services exceeding US$1.00 billion in transactions. These developments underscore how ServiceNow is positioning its workflow platform as an AI “control tower” for enterprises, embedding agentic AI across partners’...

In May 2026, Fairfax Financial’s Prem Watsa accumulated nearly 1.2 million Under Armour shares in structured blocks below US$5, coinciding with the company’s recent streak of four consecutive quarterly earnings beats and rapid international expansion. This combination of a high-profile value investor buying in size and management guiding to the first positive adjusted EPS in fiscal 2027 highlights growing confidence in Under Armour’s turnaround efforts despite ongoing North American weakness...

In its recent Q1 report, Black Stone Minerals posted EBITDA and EPS ahead of analyst forecasts while revenue came in below expectations. Despite the earnings beat on key profitability metrics, the company delivered the weakest performance versus analyst estimates among its peer group, highlighting investor sensitivity to revenue shortfalls. We’ll now examine how Black Stone Minerals’ mixed Q1 results, particularly the revenue shortfall, may reshape its existing investment...

COMPASS Pathways plc recently announced that Kathleen Tregoning has been elected to its Board of Directors, with plans for her to serve on both the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. Her background leading corporate affairs and commercial strategy at Cerevel Therapeutics, Sanofi and Biogen, combined with deep health policy experience in the U.S. Congress, adds industry, regulatory and commercialization expertise that could...

Recent performance snapshot HCI Group (HCI) has drawn investor attention after a mixed return profile, with the stock down over the past year and year to date, while still showing very large multiyear total returns. See our latest analysis for HCI Group. At a share price of $154.07, HCI’s short term momentum has cooled, with the 90 day share price return down 12.44% and the year to date share price return down 16.22%. However, the 3 year total shareholder return of 193.11% and 5 year total...

Immunocore Holdings recently reported updated Phase 1 results for its TCR bispecific brenetafusp in heavily pretreated HLA-A*02:01-positive advanced melanoma, showing a 6‑month overall survival rate of 87% and a disease control rate of 52%, and confirming 160 mcg as the dose for the ongoing Phase 3 PRISM-MEL-301 trial. This early signal of durable disease control in a difficult-to-treat melanoma population highlights how brenetafusp could broaden Immunocore’s oncology franchise beyond...

US Foods Holding stock overview after recent trading moves US Foods Holding (USFD) has drawn attention after a mixed stretch of returns, with the stock up over the past week but down around 12% over the past month and past 3 months. That performance sits alongside annual revenue of US$39.68b and net income of US$677m. These figures give investors concrete size and profitability markers as they assess whether recent share price moves align with the underlying business. See our latest analysis...

Hinge Health recently highlighted its progress since its May 2025 IPO, as CEO Daniel Perez discussed the company’s post-listing growth in a media interview alongside a pre-market update from the New York Stock Exchange trading floor. The CEO’s public focus on how the business has evolved since going public offers investors fresh insight into management priorities and execution. Against this backdrop, we’ll explore how CEO Daniel Perez’s post-IPO growth commentary may influence Hinge Health’s...

Recent performance snapshot Hubbell (HUBB) has drawn investor attention after a period where the stock is down about 7% over the past month and roughly 3% over the past 3 months, despite a positive 1‑year total return. See our latest analysis for Hubbell. The recent share price pressure, with the stock down over the past month and quarter, contrasts with a stronger 1 year total shareholder return of about 26%. This suggests momentum has cooled after a solid multi year run. If you are watching...

The Morning Bull - US Market Morning Update Monday, Jun, 1 2026 US stock futures are pointing slightly higher this morning, with E mini S&P 500 contracts up about 0.2% and Nasdaq 100 futures ahead roughly 0.3%, as investors balance strong US data, calmer inflation signals, and mixed news from China. The Chicago PMI, a key scorecard of business activity in the Midwest, jumped to 62.7 in May 2026, which hints that companies are busier and could keep profits supported. At the same time, the 10...

PVH Corp. recently announced a series of leadership changes, including promoting Adelyn Cheong to CEO of PVH Americas, creating a new President of Global Licensing, Partnerships and Expansion role for Joel Samaha, and broadening Jonathan Bottomley’s remit to EVP, Group Consumer & Brand Strategy, with additional adjustments in its China leadership structure. Together, these moves signal a sharper emphasis on consumer insights, licensing and partnerships, and regional execution for Calvin...

In late May 2026, Roku rolled out a revamped, more personalized Home Screen to over 100 million streaming households and added FOX One as a premium subscription on The Roku Channel in the U.S., offering bundled access to FOX news, sports, entertainment, and all FIFA World Cup 2026 matches. Together, these moves deepen Roku’s role as a content-discovery and subscription hub, potentially increasing user engagement while making its platform more valuable to media and advertising partners. Next,...

In late May 2026, Veeva Systems announced several wins, including Kindeva Drug Delivery adopting Veeva Quality Cloud and global Veeva Vault CRM commitments from Merck KGaA and Teva Pharmaceuticals to modernize quality and commercial operations. These deals highlight how Veeva is embedding its cloud and AI-driven platforms deeper into life sciences workflows, spanning manufacturing, R&D, and commercial execution. Next, we'll examine how Veeva's expanding enterprise footprint, particularly...

Cogent Communications Holdings (CCOI) has drawn investor attention after the stock fell about 10% in the latest session and is now down roughly 23% over the past month. See our latest analysis for Cogent Communications Holdings. The recent slide builds on a weaker trend, with the share price down over the past quarter and the 1 year total shareholder return also declining sharply. This suggests sentiment has cooled and investors may be reassessing Cogent Communications Holdings' risk and...

In late May 2026, CNBC’s Jim Cramer highlighted SELLAS Life Sciences Group on “Mad Money,” calling the biotech a “great spec” and giving it “two thumbs up,” while investors tracked progress in its Phase 3 REGAL trial for GPS in AML patients in remission but ineligible for stem cell transplant. Attention is also building around SELLAS’ second AML candidate, SLS009, with upcoming topline data viewed as a potentially important catalyst for the company’s development pipeline. With recent returns...

In late May 2026, ZenaTech announced the early-stage development of ZenaWorx, a LiDAR-based virtual design and construction progress monitoring software that combines its Drone as a Service and Enterprise SaaS capabilities to support large-scale AI data center projects. By using drone-captured LiDAR to generate detailed 3D site maps and standardized analytics, ZenaWorx aims to become a core digital layer for tracking construction performance and design deviations across complex builds. We’ll...

Recent commentary on Proto Labs highlights muted revenue growth and falling earnings per share over recent years, raising questions about the company’s demand trends and profitability as of early 2026. Analysts are increasingly focused on Proto Labs’ below-average returns on capital and relatively high valuation multiple, which together suggest the market is paying a premium despite these operational headwinds. Next, we’ll examine how concerns over muted revenue growth and declining earnings...

Recent price action and context Arcosa (ACA) has drawn fresh attention after recent trading saw the stock close at $126.75, with short term returns around 5% over the past week and mid single digit gains over the past month. See our latest analysis for Arcosa. That recent 5% 7 day share price return sits within a stronger run, with the share price up 14.9% over 90 days and year to date gains of 18.7%. The 1 year total shareholder return of 47.1% points to momentum that has been building...